Mark Pflug’s practice focuses on public and private mergers and acquisitions and private equity transactions.

He advises on all manner of transactions across the entire lifecycle of private equity sponsors’ engagement with their portfolio companies, including initial investments, consortium and partnership arrangements, follow-on acquisitions and investments, refinancings and recapitalizations, and dispositions both in public markets and sales to strategic and financial acquirors. Mark also regularly advises public and private companies on their most important M&A matters, including strategic business combinations, complex joint ventures, minority investments, as well as corporate governance matters. Mark’s practice spans multiple sectors and includes significant experience in the healthcare/life sciences, real estate services, industrial, and technology, media, and telecommunications sectors. He has extensive experience in cross-border transactions in numerous European and Asian jurisdictions.

Mark joined the firm as a partner in 2026 from another major international law firm.

Read More

Notable Experience (including those prior to joining Cleary Gottlieb)

  • KKR in numerous transactions, including the $1.4 billion acquisition of PharMerica and in PharMerica’s strategic combination with BrightSpring Health Services; acquisition of Heartland Dental; $2 billion sale of Aricent; acquisition of PetVet Care Centers; $5.5 billion sale of Capsugel; acquisition of Epicor Software; sale of Ipreo Holdings; $7.2 billion acquisition of Samson Resources; $5.8 billion sale of Oriental Brewery (Korea); sale of a majority stake in A-Gas; and acquisitions of or investments in Qingdao Haier Co. Ltd. (China), Gland Pharma Limited (India), Weststar Aviation Services Sdn. Bhd. (Malaysia), PT Tiga Pilar Sejahtera Food Tbk. (Indonesia), Alliance Tires Group B.V. (India), Fotolia Holdings Inc. (Germany), and BMG Rights Management GmbH (Germany).

  • CBRE in numerous transactions, including its acquisition of the remaining equity interests of Industrious National Management Company not otherwise held by CBRE; acquisition of a 60% interest in and strategic partnership with Turner & Townsend and subsequent combination of its Project Management Business with Turner & Townsend; acquisition of Facility Source; acquisition of J&J Worldwide Services; acquisition of Full Spectrum Group; and $125 million Series E investment in VTS.

  • CSL in multiple transactions, including its acquisition of Vifor Pharma, acquisition of Vitaeris, exclusive license of a novel late-stage gene therapy candidate for hemophilia B patients from uniQure, and formation of the COVID-19 Plasma Alliance.

  • TruArc Partners (formerly Snow Phipps) in multiple transactions, including its acquisition of Prototek, acquisition of BlackHawk Industrial Distribution, and acquisition and subsequent disposition of Winchester Electronics Corporation.

  • Gardner Denver Holdings Inc. in its merger with Ingersoll-Rand plc’s Industrial segment.

  • Alibaba Group in several acquisitions and investments.

  • Global Medical Response (formerly Air Medical Group) in its acquisition of Air Medical Resources Group and other investments.

See More

Selected Activities

trigger

Co-chair, IBA International M&A Conference, 2016-2026